Literature DB >> 21318845

Inhibition of tumor blood flow.

C Lai-Ming1, W R Wilson, B C Baguley.   

Abstract

Research into the treatment of cancer has often been driven by the idea that a common biochemical pathway might exist in all tumors, providing an ideal target for therapy. However, it is now clear that a great variety of genetic changes contributes to the development of individual cancers, and that no two cancers are identical. Nevertheless, a common feature in solid tumors is the disorganized way in which the blood vessels develop. Networks of tumor capillaries, linked to the blood supply by arterioles and venules, are necessary for tumors to grow but, in contrast to capillaries supplying normal tissue, are haphazard in both their structure and their dynamics. It may be possible to use this common feature as a basis for selective therapy. In this chapter we provide a short review of the vasculature of solid tumors, then describe methods by which drugs might be used to inhibit tumor blood flow. Finally, we review some of the methods available for measurement of tumor blood flow.

Entities:  

Year:  2000        PMID: 21318845     DOI: 10.1385/1-59259-075-6:133

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  1 in total

1.  Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a review.

Authors:  Bryan T Oronsky; Jan J Scicinski; Tony Reid; Susan Knox
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.